A. Preti
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Fernando Cabanillas (11 shared papers)Hagop Kantarjian (3 shared papers)Jorge Enrique Romaguera (10 shared papers)Filippo Canducci (2 shared papers)Elisa Rita Ceresola (2 shared papers)Roberto Ferrarese (2 shared papers)Maria Alma Rodriguez (8 shared papers)Fredrick B. Hagemeister (7 shared papers)
- Journals
- Annals of Oncology (3 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (2 papers)Blood (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
A. Preti
17 papers receiving 615 citations
Peers
Comparison fields: 5 of 77
- Pathology and Forensic Medicine 284
- Genetics 112
- Oncology 183
- Hematology 74
- Neurology 71
Countries citing papers authored by A. Preti
This map shows the geographic impact of A. Preti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Preti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Preti more than expected).
Fields of papers citing papers by A. Preti
This network shows the impact of papers produced by A. Preti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Preti. The network helps show where A. Preti may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Preti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 144 | |
| 2 | 2018 | 78 | |
| 3 | Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma. | 2000 | 59 |
| 4 | 1994 | 55 | |
| 5 | 1998 | 53 | |
| 6 | 2002 | 52 | |
| 7 | 1996 | 49 | |
| 8 | 1994 | 38 | |
| 9 | 1997 | 32 | |
| 10 | 2018 | 17 | |
| 11 | 1998 | 17 | |
| 12 | 1994 | 12 | |
| 13 | Paclitaxel (Taxol) for the treatment of lymphoma. | 1997 | 12 |
| 14 | Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy. | 1994 | 11 |
| 15 | 1997 | 11 | |
| 16 | 1999 | 5 | |
| 17 | 1997 | 5 |
About A. Preti
A. Preti is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 650 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Acute Myeloid Leukemia Research (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (284 citations), Genetics (112 citations), Oncology (183 citations), Hematology (74 citations) and Neurology (71 citations). A. Preti has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Fernando Cabanillas, Hagop Kantarjian, Jorge Enrique Romaguera, Filippo Canducci, Elisa Rita Ceresola, Roberto Ferrarese, Maria Alma Rodriguez, Fredrick B. Hagemeister, Peter Joseph McLaughlin and A H Sarris. Their work appears in journals such as Annals of Oncology, British Journal of Haematology, Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.